Glaukos Corp (NY: GKOS )

97.42 USD +2.86 (+3.02%)

Official Closing Price Updated: 7:00 PM EST, Mar 1, 2021 Add to My Watchlist

Price and Volume

Volume	482,900
Open	93.99
Bid (Size)	84.00 (1)
Ask (Size)	97.42 (12)
Prev. Close	94.56
Today's Range	93.03 - 98.26
52wk Range	23.31 - 98.26
Shares Outstanding	34,906,021
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors

March 01, 2021

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today...

Glaukos Corporation Announces Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021

Performance

YTD	+38.32%	+38.32%
1 Month	+8.82%	+8.82%
3 Month	+44.37%	+44.37%
6 Month	+103.68%	+103.68%
1 Year	+120.06%	+120.06%

More News

Glaukos Announces Positive Phase 3 Trial Results for iLink™ Epi-on Investigational Therapy That Met the Primary Efficacy Endpoint

February 25, 2021

Glaukos' iLink Therapy Meets Primary Endpoint In Late-Stage Vision Disorder Study

February 26, 2021

Glaukos: Q4 Earnings Insights

February 25, 2021

Glaukos Corporation to Release Fourth Quarter and Full Year 2020 Financial Results after Market Close on February 25

February 04, 2021

Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript

February 26, 2021

Earnings Outlook For Glaukos

February 24, 2021

Healthcare Sector Lags But Small Caps Are Strong

February 08, 2021

Interesting GKOS Put And Call Options For March 19th

February 01, 2021

The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida

February 26, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.